"We also have to remember that the world is changing when it comes to medicine pricing. Australia has negotiated very good deals for a long time but we are coming under increasing scrutiny," said AbbVie's Chris Stemple. …
AbbVie's Chris Stemple: Australia facing increased scrutiny on pricing
January 11, 2021 Latest NewsBioPharmaDispatch Executive
Latest Video
New Stories
-
Publication of ministerial advice raises questions about the evidence given at Senate Estimates
November 29, 2024 - - Latest News -
We now know what will be considered in March, but not what has been pushed to May
November 29, 2024 - - Latest News -
New data reveals how healthcare professionals can support communities to prepare for COVID-19
November 29, 2024 - - Latest News -
Stakeholders come together for consensus statement in support of 'bridging' fund
November 29, 2024 - - Latest News -
The Dispatched 'Week in Review' Podcast - 29 November
November 28, 2024 - - Podcast -
Senate backs order for the production of documents on submission deferrals
November 27, 2024 - - Latest News -
Outgoing President proposes dramatic expansion in funded access to anti-obesity therapies
November 27, 2024 - - Latest News